For the Inventor, By the Inventor

Enter assignee name

Alphora Research Inc.

USPTO Granted Patents = 18

% Expired Patents = 72.2

CIPO Patents = 3

EPO Patents = 5

Forward Citations = 43

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Boris Gorin (15 out of 32 patents)

Fabio E S Souza (7 out of 30 patents)

Ming Pan (7 out of 9 patents)

4. Ricardo Orprecio (6 out of 7 patents)

5. Dino Alberico (6 out of 8 patents)

6. Jason A Bexrud (5 out of 5 patents)

7. Joshua Clayton (5 out of 15 patents)

8. Jan Oudenes (4 out of 18 patents)

9. Craig Edward Dixon (3 out of 10 patents)

10. Alena Rudolph (3 out of 4 patents)

11. Huzaifa Rangwala (3 out of 3 patents)

12. Fabio Eduardo Silva E Souza (3 out of 3 patents)

13. Teng Ko Ngooi (2 out of 2 patents)

14. Kathleen Da Silva Turcot (2 out of 2 patents)

15. Navindra Jainarine Ramjit (2 out of 2 patents)

18 patents: Sort by Forward Citations

1. 9758464 - Continuous flow process for the preparation of Ingenol-3-mebutate (2017-09-12),

2. 9695187 - Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein (2017-07-04),

3. 9650397 - 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof (2017-05-16),

4. 9416140 - Process for preparation of 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof (2016-08-16),

5. 9403864 - Process for the synthesis of carbonucleoside and intermediates for use therein (2016-08-02),

6. 9278979 - Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein (2016-03-08),

7. 9181152 - [object Object] (2015-11-10),

8. 9174956 - Process for preparation of 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof (2015-11-03),

9. 9062020 - 2-((2S,3S,4R,5R)-5-((S)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation (2015-06-23),

10. 9029607 - Protected aldehydes for use as intermediates in chemical syntheses, and processes for their preparation (2015-05-12),

11. 8658792 - Carbanucleoside synthesis and novel intermediate compounds useful therein (2014-02-25),

12. 8513441 - Prostaglandin synthesis and intermediates for use therein (2013-08-20),

13. 8309744 - Prostaglandin synthesis and intermediates for use therein (2012-11-13),

14. 8013176 - Paricalcitol purification (2011-09-06),

15. 7928252 - Prostaglandin synthesis and intermediates for use therein (2011-04-19),

Company Overview

Alphora Research Inc. is a biotechnology firm based in California, specializing in the development of innovative solutions for drug discovery and development. The company focuses on advanced research in pharmaceutical sciences, leveraging cutting-edge technologies to enhance the efficiency and effectiveness of therapeutic compounds. With a commitment to scientific excellence, Alphora aims to address complex challenges in the healthcare sector, contributing to the advancement of medical treatments and improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

18 Patents

#28 in

#822 in Canada

#34,244 in the World

Alphora Research Inc.

Forward Citations = 43

26 inventors:

Boris Gorin (15 out of 32 patents)

Fabio E S Souza (7 out of 30 patents)

Ming Pan (7 out of 9 patents)

4. Ricardo Orprecio (6 out of 7 patents)

5. Dino Alberico (6 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alphora Research Inc.. Retrieved from https://idiyas.com/company/alphora-research

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…